Pentixapharm Holding AG (FRA:PTP) Common Stock: €24.80 Mil (As of Mar. 2026)


FRA:PTP Pentixapharm Holding AG FRA:PTP
20 GF Score
Price €2.20
! 2 Warning Signs
View Full Analysis

What is Pentixapharm Holding AG Common Stock?

Pentixapharm Holding AG FRA:PTP -4.35% 20 Common Stock is €24.80 Mil as of Mar. 2026. GuruFocus rates FRA:PTP with a GF Score™ of 20/100. The stock has 2 warning signs investors should review.

Pentixapharm Holding AG's quarterly common stock stayed the same from Sep. 2025 (€24.80 Mil) to Dec. 2025 (€24.80 Mil) and stayed the same from Dec. 2025 (€24.80 Mil) to Mar. 2026 (€24.80 Mil).

Pentixapharm Holding AG's annual common stock increased from Dec. 2023 (€21.70 Mil) to Dec. 2024 (€24.80 Mil) but then stayed the same from Dec. 2024 (€24.80 Mil) to Dec. 2025 (€24.80 Mil).

Pentixapharm Holding AG Common Stock Historical Data

* Premium members only.

The historical data trend for Pentixapharm Holding AG's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pentixapharm Holding AG Common Stock Chart

Pentixapharm Holding AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
0.09 0.09 21.70 24.80 24.80

Pentixapharm Holding AG Quarterly Data
Dec21 Dec22 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 24.80 24.80 24.80 24.80 24.80
FRA:PTP
20GF Score
Pentixapharm Holding AG FRA:PTP
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pentixapharm Holding AG Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €24.80 Mil mean?
Pentixapharm Holding AG (FRA:PTP) has a Common Stock of €24.80 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Pentixapharm Holding AG and its competitors.
Is Pentixapharm Holding AG's Common Stock too high?
Pentixapharm Holding AG's current Common Stock is €24.80 Mil. Overall, Pentixapharm Holding AG has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Pentixapharm Holding AG's Common Stock compare to VRTX and REGN?
Pentixapharm Holding AG's Common Stock of €24.80 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Pentixapharm Holding AG and its competitors. Pentixapharm Holding AG's current Common Stock is €24.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pentixapharm Holding AG stock overvalued right now?
Pentixapharm Holding AG (FRA:PTP) has a current Common Stock of €24.80 Mil. The current Common Stock is €24.80 Mil. Pentixapharm Holding AG's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Pentixapharm Holding AG (FRA:PTP), the current Common Stock is €24.80 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pentixapharm Holding AG Business Description

Other Exchanges PTP:GermanyPTPN:Austria
Address Robert-Rossle-Street 10, Berlin, DEU, 13125
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic. Its Pipeline products include: Pentixa Ther, PT-002, PentixaFor, PT-001, PentixaFor, PT-001, PT-00X, GT-001, GT-002, GT-005, GT-008, and GT-00X.
20GF Score

Get the complete analysis for FRA:PTP

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.20
Price